Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest announcement is out from Eiken Chemical Co., Ltd. ( (JP:4549) ).
Eiken Chemical Co., Ltd. has announced its opposition to a shareholder proposal from AVI Japan Opportunity Trust PLC, which includes amendments to the articles of incorporation and a buyback of shares. The company emphasizes its commitment to strengthening its governance structure with a board composed mainly of independent directors, aiming to enhance corporate value and shareholder value in the medium to long term. The board believes that maintaining decision-making authority on share buybacks and earnings appropriation within the board, rather than expanding shareholder rights, aligns with its strategic governance framework.
More about Eiken Chemical Co., Ltd.
Eiken Chemical Co., Ltd. operates in the chemical industry, focusing on the development and production of diagnostic reagents and equipment. The company is known for its innovative approach to enhancing healthcare through its products and services.
Average Trading Volume: 105,556
Technical Sentiment Signal: Hold
Current Market Cap: Yen64.09B
See more insights into 4549 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue